The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
Abstract
An excess dopaminergic activity may be implicated in the etiology of schizophrenia. Our objective was to identify nucleotide variants in the 5' region of the dopamine D2 receptor gene (DRD2) and to clarify their effects on schizophrenia. We identified two polymorphisms, the A-241G and -141C Ins/Del, by examination of 259 bp in the 5'-flanking region and 249 bp of exon 1 of DRD2. Reporter constructs containing the -141C Del allele cloned into a luciferase reporter plasmid drove 21% (Y-79 cells) and 43% (293 cells) expression compared with the -141C Ins allele. In a case-control study, the -141C Del allele frequency was significantly lower in 260 schizophrenic patients than in 312 controls (OR = 0.60, 95%CI 0.44-0.81, P < 0.001). No significant association was found between the A-241G polymorphism and in vitro luciferase activity, or in allele frequency between the patients versus controls. These findings show that the -141C Ins/Del may be a functional polymorphism in the 5'-promoter region of DRD2 and may affect the susceptibility to schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Handbook of Human Genetic Linkage.
Edwards, A. W. F., Terwilliger, J. D., & Ott, J. (1996) · Biometrics · doi:10.2307/2533082 · Cited by 869
Dopamine D4 receptors elevated in schizophrenia
Seeman, P., Guan, H.-C., & Van Tol, H. H. M. (1993) · Nature · doi:10.1038/365441a0 · Cited by 628
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Seeman, P. (1992) · PubMed · Cited by 439
Association of dopamine D2 receptor molecular variant with schizophrenia
Arinami, T., Hamaguchi, H., Itokawa, M., Enguchi, H., Tagaya, H., Yano, S., Toru, M., & Shimizu, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91581-4 · Cited by 173
Self-citationA Structural Polymorphism of Human Dopamine D2 Receptor D2(Ser311 → Cys)
Itokawa, M., Arinami, T., Futamura, N., Hamaguchi, H., & Toru, M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2404 · Cited by 139
Self-citationNo Linkage Between D2 Dopamine Receptor Gene Region and Schizophrenia
Moises, H. W. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310061011 · Cited by 121
Cited by
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.205 · Cited by 930
Jönsson, E. G., Nöthen, M. M., Grünhage, F., Farde, L., Nakashima, Y., Propping, P., & Sedvall, G. C. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000532 · Cited by 721
Pohjalainen, T., Rinne, J. O., Någren, K., Lehikoinen, P., Anttila, K., Syvälahti, E. K. G., & Hietala, J. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000350 · Cited by 673
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
Noble, E. P. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10005 · Cited by 501
Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M.-L. T., Xiao, T., Papp, A., Wang, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707106104 · Cited by 423
Single nucleotide polymorphisms and the future of genetic epidemiology
Schork, N. J., Fallin, D., & Lanchbury, J. S. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580402.x · Cited by 412
Forbes, E. E., Brown, S. M., Kimak, M., Ferrell, R. E., Manuck, S. B., & Hariri, A. R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002086 · Cited by 408
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Arranz, M. J., & de Leon, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002009 · Cited by 351
The molecular genetics of schizophrenia: new findings promise new insights
Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001444 · Cited by 321
Bondy, B., Buettner, A., & Zill, P. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001803 · Cited by 319
The genetic basis for smoking behavior: A systematic review and meta-analysis
Munafò, M., Clark, T., Johnstone, E., Murphy, M., & Walton, R. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001734030 · Cited by 312
Ritchie, T., & Noble, E. P. (2003) · Neurochemical Research · doi:10.1023/a:1021648128758 · Cited by 292
Molecular Mechanisms of Schizophrenia
Lang, U. E., Puls, I., Müller, D. J., Strutz-Seebohm, N., & Gallinat, J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110430 · Cited by 281
Individual differences in extraversion and dopamine genetics predict neural reward responses
Cohen, M. X., Young, J., Baek, J.-M., Kessler, C., & Ranganath, C. (2005) · Cognitive Brain Research · doi:10.1016/j.cogbrainres.2005.09.018 · Cited by 272
Multilocus Genetic Profile for Dopamine Signaling Predicts Ventral Striatum Reactivity
Nikolova, Y. S., Ferrell, R. E., Manuck, S. B., & Hariri, A. R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.82 · Cited by 269
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
Lett, T. A. P., Wallace, T. J. M., Chowdhury, N. I., Tiwari, A. K., Kennedy, J. L., & Müller, D. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.109 · Cited by 264
Hatsukami, D. K., Stead, L. F., & Gupta, P. C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60871-5 · Cited by 227
Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes
Tost, H., Alam, T., & Meyer-Lindenberg, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.005 · Cited by 160
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus
Kidd, K. K., Morar, B., Castiglione, C. M., Zhao, H., Pakstis, A. J., Speed, W. C., Bonne-Tamir, B., Lu, R.-B., Goldman, D., Lee, C., et al. (1998) · Human Genetics · doi:10.1007/s004390050809 · Cited by 141
Association of Multiple DRD2 Polymorphisms with Anorexia Nervosa
Bergen, A. W., Yeager, M., Welch, R. A., Haque, K., Ganjei, J. K., van den Bree, M. B. M., Mazzanti, C., Nardi, I., Fichter, M. M., Halmi, K. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300719 · Cited by 137
Kaalund, S. S., Newburn, E. N., Ye, T., Tao, R., Li, C., Deep-Soboslay, A., Herman, M. M., Hyde, T. M., Weinberger, D. R., Lipska, B. K., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.165 · Cited by 132
Developmental imaging genetics: Linking dopamine function to adolescent behavior
Padmanabhan, A., & Luna, B. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2013.09.011 · Cited by 87
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78
Hettinger, J. A., Liu, X., Hudson, M. L., Lee, A., Cohen, I. L., Michaelis, R. C., Schwartz, C. E., Lewis, S. M., & Holden, J. J. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-19 · Cited by 68
Shi, S., Leites, C., He, D., Schwartz, D., Moy, W., Shi, J., & Duan, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535203 · Cited by 61
Herzberg, I., Valencia-Duarte, A. V., Kay, V. A., White, D. J., Müller, H., Rivas, I. C., Mesa, S. C., Cuartas, M., García, J., Bedoya, G., et al. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a215a · Cited by 36
From Transcriptional Regulation to Aggressive Behavior
D'Souza, U. M., Kel, A., & Sluyter, F. (2003) · Behavior Genetics · doi:10.1023/a:1025778817885 · Cited by 12
Dobewall, H., Keltikangas‐Järvinen, L., Saarinen, A., Lyytikäinen, L., Zwir, I., Cloninger, R., Raitakari, O. T., Lehtimäki, T., & Hintsanen, M. (2021) · Developmental Psychobiology · doi:10.1002/dev.22184 · Cited by 2
Metadata
- Authors
- Arinami, T.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-04-01
- Volume
- 6
- Issue
- 4
- Pages
- 577-582
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2140915307
- Cited by
- 455
- References
- 24
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.